Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease D Kaur, V Sharma, R Deshmukh Inflammopharmacology 27, 663-677, 2019 | 414 | 2019 |
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor R Deshmukh, V Sharma, S Mehan, N Sharma, KL Bedi European journal of pharmacology 620 (1-3), 49-56, 2009 | 258 | 2009 |
Hypoglycemic activity of Ficus glomerata in alloxan induced diabetic rats VK Sharma, S Kumar, HJ Patel, S Hugar International Journal of Pharmaceutical Sciences Review and Research 1 (2 …, 2010 | 198 | 2010 |
Apoptotic pathways and Alzheimer’s disease: probing therapeutic potential VK Sharma, TG Singh, S Singh, N Garg, S Dhiman Neurochemical research 46 (12), 3103-3122, 2021 | 154 | 2021 |
Chronic stress and diabetes mellitus: interwoven pathologies VK Sharma, TG Singh Current diabetes reviews 16 (6), 546-556, 2020 | 114 | 2020 |
Alzheimer’s disorder: epigenetic connection and associated risk factors VK Sharma, V Mehta, TG Singh Current neuropharmacology 18 (8), 740-753, 2020 | 107 | 2020 |
CREB: a multifaceted target for Alzheimer’s disease VK Sharma, TG Singh Current Alzheimer Research 17 (14), 1280-1293, 2020 | 91 | 2020 |
Dysbiosis and Alzheimer’s disease: a role for chronic stress? VK Sharma, TG Singh, N Garg, S Dhiman, S Gupta, MH Rahman, A Najda, ... Biomolecules 11 (05), 678, 2021 | 77 | 2021 |
Stressed mitochondria: A target to intrude Alzheimer’s disease VK Sharma, TG Singh, V Mehta Mitochondrion 59, 48-57, 2021 | 54 | 2021 |
Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease VK Sharma, TG Singh Life Sciences 262, 118401, 2020 | 47 | 2020 |
Reviving mitochondrial bioenergetics: a relevant approach in epilepsy S Singh, TG Singh, AK Rehni, V Sharma, M Singh, R Kaur Mitochondrion 58, 213-226, 2021 | 46 | 2021 |
Tumor necrosis factor and Alzheimer's disease: a cause and consequence relationship V Sharma, V Thakur, SN Singh, R Guleria Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 22 …, 2012 | 43 | 2012 |
Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats V Sharma, A Bala, R Deshmukh, KL Bedi, PL Sharma Pharmacology Biochemistry and Behavior 101 (2), 239-245, 2012 | 42 | 2012 |
Streptozotocin: an experimental tool in diabetes and alzheimer’s disease (A-Review) KS Vivek Int J Pharma Res Dev 2 (1), 1-7, 2010 | 33 | 2010 |
Kynurenine metabolism and Alzheimer’s disease: the potential targets and approaches VK Sharma, TG Singh, NK Prabhakar, A Mannan Neurochemical Research 47 (6), 1459-1476, 2022 | 32 | 2022 |
Navigating Alzheimer’s Disease via Chronic Stress: The Role of Glucocorticoids VK Sharma, TG Singh Current drug targets 21 (5), 433-444, 2020 | 32 | 2020 |
Therapeutic implications of sonic hedgehog pathway in metabolic disorders: Novel target for effective treatment C Garg, A Kaur, TG Singh, VK Sharma, SK Singh Pharmacological Research 179, 106194, 2022 | 30 | 2022 |
Morris water maze–a versatile cognitive tool VK Sharma memory 8 (9), 2009 | 28 | 2009 |
Cyclic nucleotides signaling and phosphodiesterase inhibition: defying Alzheimer’s disease VK Sharma, TG Singh, S Singh Current Drug Targets 21 (13), 1371-1384, 2020 | 22 | 2020 |
Biomarkers: Role and scope in neurological disorders VK Sharma, TG Singh, V Mehta, A Mannan Neurochemical Research 48 (7), 2029-2058, 2023 | 18 | 2023 |